Abstract
The 23 valent pneumococcal polysaccharide vaccine (PPV) is often used to assess an individual’s ability to produce antibodies to polysaccharides. The Luminex xMAP microsphere-based liquid array system, when applied to the determination of antibodies to pneumococcal polysaccharides (PnPs), allows for the antibody response to the 23 serotypes to be determined simultaneously. Multiplexing saves considerable time and expense over the traditional method of testing each PnPs serotype individually by the enzyme-linked immunosorbent assay (ELISA). This chapter describes methods for (a) conjugation of poly-l-lysine (PLL) to PnPs, (b) coupling of PnPs–PLL conjugates to Luminex microspheres, and (c) a multiplex Luminex assay for the measurement of serotype-specific IgG concentrations to pneumococcal serotypes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Musher, DM (1992) Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 14:801–807
Whitney CG, Farley MM, Hadler J, et al (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. New Engl J Med 348:1737–1746
Dagan R, Givon-Lavi N, Zamir O et al (2002) Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 185:927–936
Goldblatt D, Hussain M, Andrews N et al (2005) Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis 192:387–393
Picard C, Puel A, Bustamante J et al (2003) Primary immunodeficiencies associated with pneumococcal disease. Curr Opin Allergy Clin Immunol 3:451–459
Rijkers GT, Sanders LA, Zegers B J (1993) Anti-capsular polysaccharide antibody deficiency states. Immunodeficiency 5:1–21
Cheng YK, Decker, PA, O’ByrneMM et al (2006) Clinical and laboratory characteristics of 75 patients with specific polysaccharide antibody deficiency syndrome. Ann Allergy Asthma Immunol 97:306–311
Go, ES, Ballas Z K (1996) Anti-pneumococcal antibody response in normal subjects: a meta-analysis. J Allergy Clin Immunol 98:205–215
Paris K, Sorensen RU (2007) Assessment and clinical interpretation of polysaccharide antibody responses. Ann Allergy Asthma Immunol 99:462–464
Bryant KA, Block SL, Baker SA et al (2010) Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine. Pediatrics 125:866–875
Wernette CM, Frasch, CE, Madore D et al (2003) Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol 10:514–519
Concepcion NF, Frasch CF (2001) Pneumococcal type 22 F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 8:266–72
Pickering JW, Martins TB, Greer RW et al (2002) A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides. Am J Clin Path 117:589–596
Lal G, Balmer P, Stanford E et al (2005) Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes. J Immunol Meth 296:135–147
Elberse KE, Tcherniaeva I, Berbers GA et al (2010) Optimization and application of a multiplex bead-based assay to quantify serotype-specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with the pneumococcal 7-valent conjugate vaccine. Clin Vaccine Immunol 17:674–682
Biagini RE, Schlottmann SA, Sammons DL et al (2003) Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides. Clin Diagn Lab Immunol 10:744–750
Schlottmann, S. A., Jain, N., Chirmule, N. and Esser, M. T. (2006) A novel chemistry for conjugating pneumococcal polysaccharides to Luminex microspheres. J Immunol Methods 309:75–85
Borgers H, Moens L, Picard C et al (2010) Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens by multiplexed bead assay. Clin Immunol 134:198–205
Pickering JW, Larson MT, Martins TB et al (2010) Elimination of false-positive results in a luminex assay for pneumococcal antibodies. Clin Vaccine Immunol 17:185–189
Waterboer T, Sehr P, Pawlita M (2005) Supression of non-specific binding in serological Luminex assays. J Immunol Methods 309:200–204
Marchese RD, Jain NT, Antonello J et al (2006) Enzyme-linked immunosorbent assay for measuring antibodies to pneumococcal polysaccharides for the PNEUMOVAX 23 vaccine: assay operating characteristics and correlation to the WHO international assay. Clin Vaccine Immunol 13:905–912
Skovsted IC, Kerrn MB, Sonne-Hansen J et al (2007) Purification and structure characterization of the active component in the pneumococcal 22 F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays. Vaccine 25:6490–6500
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Pickering, J.W., Hill, H.R. (2012). Measurement of Antibodies to Pneumococcal Polysaccharides with Luminex xMAP Microsphere-Based Liquid Arrays. In: Chevolot, Y. (eds) Carbohydrate Microarrays. Methods in Molecular Biology, vol 808. Humana Press. https://doi.org/10.1007/978-1-61779-373-8_24
Download citation
DOI: https://doi.org/10.1007/978-1-61779-373-8_24
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-372-1
Online ISBN: 978-1-61779-373-8
eBook Packages: Springer Protocols